BioCentury
ARTICLE | Clinical News

ALD-201: Phase I data

November 23, 2009 8:00 AM UTC

Data from a double-blind Phase I trial in 20 patients showed that transendocardial injection of ALD-201 led to a mean reduction in ischemia as measured by SPECT cardiac imaging of 4% vs. a 3.7% mean i...